News
German vaccine maker BioNTech said on Tuesday that it plans to invest up to 1 billion pounds ($1.33 billion) over the next ...
Roughly five months after AstraZeneca scrapped a major investment plan in its home country, the United Kingdom has found a ...
Under the deal, BioNTech had undertaken to enroll up to 10,000 patients in clinical trials by the end of 2030 for personalized cancer therapies and make investments to expand the company's footprint ...
Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the United Kingdom over the next 10 years.
The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...
The change will also more closely align the U.S.’ policy to that of other countries, including the United Kingdom ... by the science behind the Pfizer-BioNTech COVID-19 vaccine and continue ...
After delays, the FDA has greenlit the Novavax COVID vaccine for targeted groups. Learn more about the approval and what it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results